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Nanotechnology has started a new era in biomaterial engineering and multifunctional nanoparticles 
(NPs) to improve diagnosis and therapy of various diseases, incorporating both contrast agents for 
imaging and drugs for therapy, has been designed.  
Drug loaded nanoparticles (NPs) can improve the delivery of drugs to tumors and reduce toxic 
side-effects in normal tissue due to leaky blood vessels in tumor tissue, which do not exist in normal 
tissue. However, the blood vessel leakiness is heterogeneous in tumors, and NPs that can cross the 
capillary wall have problems penetrating the extracellular matrix around the cancer cells. Thus it is 
essential to enhance the delivery to all tumor tissue in order to improve the therapeutic outcome. 
Furthermore, new designs of NP based drug delivery system are needed to secure efficient drug 
release within tumors after accumulation of the NP drugs.   
A challenge in cancer treatment is the delivery of drugs to brain tumors due the restriction of 
access to the brain that is strictly controlled by the blood-brain barrier (BBB). The endothelial cells 
forming the vessel wall are tightly linked together forming a physical barrier. Therefore, for inoperable 
diseases, non-invasive approaches for controlled transient opening of the BBB enabling the passage of 
therapeutics into the brain are highly needed. 
Focused ultrasound has been shown both to improve the delivery of NPs to tumors (Eggen et 
al., 2014) and to temporarily open the BBB (Åslund et al., 2015). 
A novel bio-responsive NP platform based on matrix metalloprotease (MMP) activatable 
liposomes will be used (Bruun et al., 2015).  MMPs are over-expressed in cancerous tissue and thus 
favorable for tumor targeting of nanoparticles for efficient drug release after tumor accumulation. 
These NPs have already show promising results in preclinical studies and in the present project 
we aim at improving the delivery of these bio-responsive NPs to tumors and subcutaneous tumors by 
exposure to focused ultrasound in the presence of microbubbles. Improved delivery of NPs will be 
imaged by MRI, PET, small animal optical imaging and multiphoton microscopy. The therapeutic effect 
will be studied by measuring tumor growth. 
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